lamotrigine

Generic: lamotrigine

Labeler: asclemed usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name lamotrigine
Generic Name lamotrigine
Labeler asclemed usa, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

lamotrigine 200 mg/1

Manufacturer
Asclemed USA, Inc.

Identifiers & Regulatory

Product NDC 76420-182
Product ID 76420-182_b19b2211-34a8-759d-e053-2a95a90af002
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA090170
Listing Expiration 2026-12-31
Marketing Start 2011-11-01

Pharmacologic Class

Established (EPC)
anti-epileptic agent [epc] mood stabilizer [epc]
Mechanism of Action
organic cation transporter 2 inhibitors [moa] dihydrofolate reductase inhibitors [moa]
Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 76420182
Hyphenated Format 76420-182

Supplemental Identifiers

RxCUI
198429
UNII
U3H27498KS
NUI
N0000175753 N0000008486 N0000175751 N0000187061 N0000000191

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lamotrigine (source: ndc)
Generic Name lamotrigine (source: ndc)
Application Number ANDA090170 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 200 mg/1
source: ndc
Packaging
  • 60 TABLET in 1 BOTTLE, PLASTIC (76420-182-60)
source: ndc

Packages (1)

76420-182-60 60 TABLET in 1 BOTTLE, PLASTIC (76420-182-60)

Ingredients (1)

lamotrigine (200 mg/1)

Linked Drug Pages (1)

Lamotrigine ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "b19b2211-34a8-759d-e053-2a95a90af002", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "unii": ["U3H27498KS"], "rxcui": ["198429"], "spl_set_id": ["8ac9dc83-edb2-4ae5-8064-40f113fd3aab"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE, PLASTIC (76420-182-60)", "package_ndc": "76420-182-60", "marketing_start_date": "20201014"}], "brand_name": "Lamotrigine", "product_id": "76420-182_b19b2211-34a8-759d-e053-2a95a90af002", "dosage_form": "TABLET", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "76420-182", "generic_name": "Lamotrigine", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamotrigine", "active_ingredients": [{"name": "LAMOTRIGINE", "strength": "200 mg/1"}], "application_number": "ANDA090170", "marketing_category": "ANDA", "marketing_start_date": "20111101", "listing_expiration_date": "20261231"}